| Year |
Citation |
Score |
| 2023 |
Lee SK, Malik R, Zhou J, Wang W, Gross P, Weitz J, Ramachandran R, Trigatti BL. PAR4 Inhibition Reduces Coronary Artery Atherosclerosis and Myocardial Fibrosis in SR-B1/LDLR Double Knockout Mice. Arteriosclerosis, Thrombosis, and Vascular Biology. PMID 37675637 DOI: 10.1161/ATVBAHA.123.319767 |
0.364 |
|
| 2023 |
Fuller MT, Dadoo O, Xiong T, Chivukula P, MacDonald ME, Lee SK, Austin RC, Igdoura SA, Trigatti BL. Extensive diet-induced atherosclerosis in scavenger receptor class B type 1-deficient mice is associated with substantial leukocytosis and elevated vascular cell adhesion molecule-1 expression in coronary artery endothelium. Frontiers in Physiology. 13: 1023397. PMID 36714321 DOI: 10.3389/fphys.2022.1023397 |
0.498 |
|
| 2022 |
Kluck GEG, Qian AS, Sakarya EH, Quach H, Deng YD, Trigatti BL. Apolipoprotein A1 Protects Against Necrotic Core Development in Atherosclerotic Plaques: PDZK1-Dependent High-Density Lipoprotein Suppression of Necroptosis in Macrophages. Arteriosclerosis, Thrombosis, and Vascular Biology. 43: 45-63. PMID 36353992 DOI: 10.1161/ATVBAHA.122.318062 |
0.346 |
|
| 2021 |
Kluck GEG, Yoo JA, Sakarya EH, Trigatti BL. Good Cholesterol Gone Bad? HDL and COVID-19. International Journal of Molecular Sciences. 22. PMID 34638523 DOI: 10.3390/ijms221910182 |
0.349 |
|
| 2019 |
Durham K, Kluck G, Mak KC, Deng YD, Trigatti BL. Treatment with apolipoprotein A1 protects mice against doxorubicin-induced cardiotoxicity in a scavenger receptor class B type I dependent manner. American Journal of Physiology. Heart and Circulatory Physiology. PMID 31002281 DOI: 10.1152/ajpheart.00432.2018 |
0.411 |
|
| 2018 |
Gonzalez L, MacDonald ME, Deng YD, Trigatti BL. Hyperglycemia Aggravates Diet-Induced Coronary Artery Disease and Myocardial Infarction in SR-B1-Knockout/ApoE-Hypomorphic Mice. Frontiers in Physiology. 9: 1398. PMID 30356742 DOI: 10.3389/fphys.2018.01398 |
0.301 |
|
| 2018 |
Yu P, Qian AS, Chathely KM, Trigatti BL. Data on leukocyte PDZK1 deficiency affecting macrophage apoptosis but not monocyte recruitment, cell proliferation, macrophage abundance or ER stress in atherosclerotic . Data in Brief. 19: 1148-1161. PMID 30246067 DOI: 10.1016/j.dib.2018.05.128 |
0.43 |
|
| 2018 |
White EJ, Gyulay G, Lhoták Š, Szewczyk MM, Chong T, Fuller MT, Dadoo O, Fox-Robichaud AE, Austin RC, Trigatti B, Igdoura SA. Sialidase down-regulation reduces non-HDL cholesterol, inhibits leukocyte transmigration and attenuates atherosclerosis in ApoE knockout mice. The Journal of Biological Chemistry. PMID 30097518 DOI: 10.1074/jbc.RA118.004589 |
0.474 |
|
| 2018 |
Grin PM, Dwivedi DJ, Chathely KM, Trigatti BL, Prat A, Seidah NG, Liaw PC, Fox-Robichaud AE. Low-density lipoprotein (LDL)-dependent uptake of Gram-positive lipoteichoic acid and Gram-negative lipopolysaccharide occurs through LDL receptor. Scientific Reports. 8: 10496. PMID 30002483 DOI: 10.1038/S41598-018-28777-0 |
0.386 |
|
| 2018 |
Yu P, Qian AS, Chathely KM, Trigatti BL. PDZK1 in leukocytes protects against cellular apoptosis and necrotic core development in atherosclerotic plaques in high fat diet fed ldl receptor deficient mice. Atherosclerosis. PMID 29853191 DOI: 10.1016/j.atherosclerosis.2018.05.009 |
0.421 |
|
| 2018 |
Lebeau P, Platko K, Al-Hashimi AA, Byun JH, Lhoták Š, Holzapfel N, Gyulay G, Igdoura SA, Cool D, Trigatti B, Seidah NG, Austin RC. Loss-of-function PCSK9 mutants evade the unfolded protein response sensor, GRP78, and fail to induce endoplasmic reticulum stress when retained. The Journal of Biological Chemistry. PMID 29593095 DOI: 10.1016/J.Atherosclerosissup.2018.04.426 |
0.369 |
|
| 2018 |
Durham KK, Chathely KM, Trigatti BL. High density lipoprotein protects cardiomyocytes against necrosis induced by oxygen and glucose deprivation, through SR-B1, PI3K, and AKT1 and 2. The Biochemical Journal. PMID 29523748 DOI: 10.1042/BCJ20170703 |
0.365 |
|
| 2018 |
Qian AS, Yu P, Gonzalez L, Trigatti B. Effects of Hematopoietic Deficiency of Pro-apoptotic Protein Bim on the Development of Atherosclerosis Atherosclerosis Supplements. 32: 100. DOI: 10.1016/J.Atherosclerosissup.2018.04.305 |
0.302 |
|
| 2018 |
Lee SK, Fuller MT, Trigatti BL. Scavenger Class B Type 1 Knockout Mice Develop Extensive Diet-Induced Aortic Sinus and Coronary Artery Atherosclerosis in an Age-Dependent Manner Atherosclerosis Supplements. 32: 95-96. DOI: 10.1016/j.atherosclerosissup.2018.04.290 |
0.304 |
|
| 2018 |
Xiong T, Yu P, Lebeau P, Austin RC, Trigatti BL. Hepatic Cholesterol Dysregulation in SR-B1/ApoE dKO Mice Atherosclerosis Supplements. 32: 38-39. DOI: 10.1016/j.atherosclerosissup.2018.04.111 |
0.397 |
|
| 2018 |
Chathely K, González L, Trigatti BL. High Density Lipoprotein Mediated Protection of Macrophages against Apoptosis Requires Scavenger Receptor Class B Type 1 Activity and Sphingosine-1-Phosphate Atherosclerosis Supplements. 32: 34. DOI: 10.1016/j.atherosclerosissup.2018.04.097 |
0.346 |
|
| 2017 |
Gonzalez L, Qian AS, Tahir U, Yu P, Trigatti BL. Sphingosine-1-Phosphate Receptor 1, Expressed in Myeloid Cells, Slows Diet-Induced Atherosclerosis and Protects against Macrophage Apoptosis in Ldlr KO Mice. International Journal of Molecular Sciences. 18. PMID 29244772 DOI: 10.3390/ijms18122721 |
0.466 |
|
| 2017 |
Yu P, Xiong T, Tenedero CB, Lebeau P, Ni R, MacDonald ME, Gross PL, Austin RC, Trigatti BL. Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering. Arteriosclerosis, Thrombosis, and Vascular Biology. PMID 29162602 DOI: 10.1161/ATVBAHA.117.305140 |
0.368 |
|
| 2017 |
Durham K, Chathely K, Mak KC, Momen A, Thomas CT, Zhao YY, MacDonald ME, Curtis JM, Husain M, Trigatti BL. HDL protects against doxorubicin induced cardiotoxicity in a scavenger receptor class B type 1, PI3K, and AKT dependent manner. American Journal of Physiology. Heart and Circulatory Physiology. ajpheart.00521.2016. PMID 28986362 DOI: 10.1152/Ajpheart.00521.2016 |
0.398 |
|
| 2017 |
Trigatti BL. SR-B1 and PDZK1: partners in HDL regulation. Current Opinion in Lipidology. PMID 28134663 DOI: 10.1097/MOL.0000000000000396 |
0.369 |
|
| 2016 |
Lebeau P, Al-Hashimi A, Sood S, Lhotak S, Yu P, Gyulay G, Pare G, Chen SR, Trigatti B, Pratt A, Seidah N, Austin RC. Endoplasmic reticulum stress and Ca2+ depletion differentially modulate the sterol-regulatory protein PCSK9 to control lipid metabolism. The Journal of Biological Chemistry. PMID 27909053 DOI: 10.1074/Jbc.M116.744235 |
0.475 |
|
| 2015 |
Trigatti BL, Fuller M. HDL signaling and protection against coronary artery atherosclerosis in mice. Journal of Biomedical Research. 30. PMID 26642235 DOI: 10.7555/JBR.30.20150079 |
0.438 |
|
| 2015 |
Lino M, Farr S, Baker C, Fuller M, Trigatti B, Adeli K. Intestinal scavenger receptor class B type I (SR-BI) as a novel regulator of chylomicron production in healthy and diet-induced obese states. American Journal of Physiology. Gastrointestinal and Liver Physiology. ajpgi.00086.2015. PMID 26138463 DOI: 10.1152/Ajpgi.00086.2015 |
0.495 |
|
| 2014 |
Fuller M, Dadoo O, Serkis V, Abutouk D, MacDonald M, Dhingani N, Macri J, Igdoura SA, Trigatti BL. The effects of diet on occlusive coronary artery atherosclerosis and myocardial infarction in scavenger receptor class B, type 1/low-density lipoprotein receptor double knockout mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 34: 2394-403. PMID 25212235 DOI: 10.1161/ATVBAHA.114.304200 |
0.461 |
|
| 2014 |
Al-Jarallah A, Chen X, González L, Trigatti BL. High density lipoprotein stimulated migration of macrophages depends on the scavenger receptor class B, type I, PDZK1 and Akt1 and is blocked by sphingosine 1 phosphate receptor antagonists. Plos One. 9: e106487. PMID 25188469 DOI: 10.1371/journal.pone.0106487 |
0.368 |
|
| 2013 |
Pei Y, Chen X, Aboutouk D, Fuller MT, Dadoo O, Yu P, White EJ, Igdoura SA, Trigatti BL. SR-BI in bone marrow derived cells protects mice from diet induced coronary artery atherosclerosis and myocardial infarction. Plos One. 8: e72492. PMID 23967310 DOI: 10.1371/journal.pone.0072492 |
0.401 |
|
| 2013 |
Hossain GS, Lynn EG, Maclean KN, Zhou J, Dickhout JG, Lhoták S, Trigatti B, Capone J, Rho J, Tang D, McCulloch CA, Al-Bondokji I, Malloy MJ, Pullinger CR, Kane JP, et al. Deficiency of TDAG51 protects against atherosclerosis by modulating apoptosis, cholesterol efflux, and peroxiredoxin-1 expression. Journal of the American Heart Association. 2: e000134. PMID 23686369 DOI: 10.1161/Jaha.113.000134 |
0.348 |
|
| 2013 |
Gonzalez L, Werstuck G, Trigatti B. Effect of Diabetes on Atherosclerosis and Myocardial Infarction in SR-BI-/-APOE Hypomorphic Mice Canadian Journal of Cardiology. 29: S175-S176. DOI: 10.1016/J.Cjca.2013.07.272 |
0.366 |
|
| 2013 |
Dadoo O, Ashkar A, Richards C, Trigatti B. Interleukin 15 Plays an Important Role in the Development of Atherosclerosis in Mice Canadian Journal of Cardiology. 29: S172-S173. DOI: 10.1016/J.Cjca.2013.07.265 |
0.393 |
|
| 2013 |
Yu P, Zhang Y, Trigatti B. Hdl Protects Macrophages Against Apoptosis in a PDZK1-Dependent Manner Canadian Journal of Cardiology. 29: S166. DOI: 10.1016/J.Cjca.2013.07.251 |
0.356 |
|
| 2012 |
Yang A, Gyulay G, Mitchell M, White E, Trigatti BL, Igdoura SA. Hypomorphic sialidase expression decreases serum cholesterol by downregulation of VLDL production in mice. Journal of Lipid Research. 53: 2573-85. PMID 22984145 DOI: 10.1194/jlr.M027300 |
0.453 |
|
| 2012 |
Johnson BB, Moe PC, Wang D, Rossi K, Trigatti BL, Heuck AP. Modifications in perfringolysin O domain 4 alter the cholesterol concentration threshold required for binding. Biochemistry. 51: 3373-82. PMID 22482748 DOI: 10.1021/Bi3003132 |
0.368 |
|
| 2012 |
Pei Y, Yu P, Fuller M, Chen X, Trigatti B. 418 Expression of SR-BI in Bone Marrow Derived Cells Protects Against Diet-Induced Coronary Artery Atherosclerosis in SR-BI−/−apoE-R61-Hypomorphic Mice Canadian Journal of Cardiology. 28: S256. DOI: 10.1016/j.cjca.2012.07.393 |
0.312 |
|
| 2011 |
Hayashi AA, Webb J, Choi J, Baker C, Lino M, Trigatti B, Trajcevski KE, Hawke TJ, Adeli K. Intestinal SR-BI is upregulated in insulin-resistant states and is associated with overproduction of intestinal apoB48-containing lipoproteins. American Journal of Physiology. Gastrointestinal and Liver Physiology. 301: G326-37. PMID 21546579 DOI: 10.1152/Ajpgi.00425.2010 |
0.386 |
|
| 2011 |
Dadoo O, Ashkar A, Richards C, Trigatti B. 368 INTERLEUKIN 15 PLAYS AN IMPORTANT ROLE IN ATHEROGENESIS IN APOLIPOPROTEIN E KNOCKOUT MICE Atherosclerosis Supplements. 12: 79. DOI: 10.1016/S1567-5688(11)70369-5 |
0.395 |
|
| 2011 |
Dadoo O, Ashkar A, Richards C, Trigatti B. 486 Interleukin 15 promotes atherosclerosis in apolipoprotein E knockout mice Canadian Journal of Cardiology. 27: S238. DOI: 10.1016/J.Cjca.2011.07.407 |
0.412 |
|
| 2010 |
Al-Jarallah A, Trigatti BL. A role for the scavenger receptor, class B type I in high density lipoprotein dependent activation of cellular signaling pathways. Biochimica Et Biophysica Acta. 1801: 1239-48. PMID 20732452 DOI: 10.1016/j.bbalip.2010.08.006 |
0.421 |
|
| 2010 |
Dadoo O, Ashkar A, Richards C, Trigatti B. MS541 INTERLEUKIN 15 (IL15) DEFICIENCY DECREASES ATHEROSCLEROSIS IN APOLIPOPROTEIN E KNOCKOUT MICE (APOE KO) Atherosclerosis Supplements. 11: 218-219. DOI: 10.1016/S1567-5688(10)71041-2 |
0.366 |
|
| 2009 |
Robichaud JC, van der Veen JN, Yao Z, Trigatti B, Vance DE. Hepatic uptake and metabolism of phosphatidylcholine associated with high density lipoproteins. Biochimica Et Biophysica Acta. 1790: 538-51. PMID 19250958 DOI: 10.1016/J.Bbagen.2009.02.010 |
0.436 |
|
| 2009 |
Dadoo O, Richards C, Ashkar A, Trigatti B. Abstract: P643 INTERLEUKIN 15 DEFICIENCY DECREASES ATHEROSCLEROSIS IN APOLIPOPROTEIN E KNOCKOUT MICE Atherosclerosis Supplements. 10: e829. DOI: 10.1016/S1567-5688(09)70811-6 |
0.398 |
|
| 2008 |
Xiao C, Watanabe T, Zhang Y, Trigatti B, Szeto L, Connelly PW, Marcovina S, Vaisar T, Heinecke JW, Lewis GF. Enhanced cellular uptake of remnant high-density lipoprotein particles: a mechanism for high-density lipoprotein lowering in insulin resistance and hypertriglyceridemia. Circulation Research. 103: 159-66. PMID 18556574 DOI: 10.1161/Circresaha.108.178756 |
0.495 |
|
| 2008 |
Zhou J, Werstuck GH, Lhoták S, Shi YY, Tedesco V, Trigatti B, Dickhout J, Majors AK, DiBello PM, Jacobsen DW, Austin RC. Hyperhomocysteinemia induced by methionine supplementation does not independently cause atherosclerosis in C57BL/6J mice. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 22: 2569-78. PMID 18364397 DOI: 10.1096/Fj.07-105353 |
0.456 |
|
| 2008 |
Braun A, Rigotti A, Trigatti BL. Myocardial infarction following atherosclerosis in murine models. Current Drug Targets. 9: 217-23. PMID 18336240 |
0.337 |
|
| 2008 |
Minahk C, Kim KW, Nelson R, Trigatti B, Lehner R, Vance DE. Conversion of low density lipoprotein-associated phosphatidylcholine to triacylglycerol by primary hepatocytes. The Journal of Biological Chemistry. 283: 6449-58. PMID 18175806 DOI: 10.1074/Jbc.M706995200 |
0.487 |
|
| 2008 |
Scott M, Beitz J, Trigatti B, Richards CD. 132 Oncostatin M induces interleukin-17 receptor a and synergistic responses to interleukin-17 in mouse aortic adventitial fibroblasts Cytokine. 43: 267. DOI: 10.1016/J.Cyto.2008.07.174 |
0.311 |
|
| 2007 |
Zhang Y, Ahmed AM, Tran TL, Lin J, McFarlane N, Boreham DR, Igdoura SA, Truant R, Trigatti BL. The inhibition of endocytosis affects HDL-lipid uptake mediated by the human scavenger receptor class B type I. Molecular Membrane Biology. 24: 442-54. PMID 17710648 DOI: 10.1080/09687680701300410 |
0.422 |
|
| 2007 |
Delvecchio CJ, Bilan P, Radford K, Stephen J, Trigatti BL, Cox G, Parameswaran K, Capone JP. Liver X receptor stimulates cholesterol efflux and inhibits expression of proinflammatory mediators in human airway smooth muscle cells. Molecular Endocrinology (Baltimore, Md.). 21: 1324-34. PMID 17405904 DOI: 10.1210/Me.2007-0017 |
0.314 |
|
| 2007 |
Covey SD, Brunet RH, Gandhi SG, McFarlane N, Boreham DR, Gerber GE, Trigatti BL. Cholesterol depletion inhibits fatty acid uptake without affecting CD36 or caveolin-1 distribution in adipocytes. Biochemical and Biophysical Research Communications. 355: 67-71. PMID 17291449 DOI: 10.1016/J.Bbrc.2007.01.135 |
0.623 |
|
| 2007 |
Zhang Y, Ahmed AM, McFarlane N, Capone C, Boreham DR, Truant R, Igdoura SA, Trigatti BL. Regulation of SR-BI-mediated selective lipid uptake in Chinese hamster ovary-derived cells by protein kinase signaling pathways. Journal of Lipid Research. 48: 405-16. PMID 17079793 DOI: 10.1194/Jlr.M600326-Jlr200 |
0.383 |
|
| 2006 |
Karackattu SL, Trigatti B, Krieger M. Hepatic lipase deficiency delays atherosclerosis, myocardial infarction, and cardiac dysfunction and extends lifespan in SR-BI/apolipoprotein E double knockout mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 26: 548-54. PMID 16397139 DOI: 10.1161/01.Atv.0000202662.63876.02 |
0.453 |
|
| 2006 |
Werstuck GH, Khan MI, Femia G, Kim AJ, Tedesco V, Trigatti B, Shi Y. Glucosamine-induced endoplasmic reticulum dysfunction is associated with accelerated atherosclerosis in a hyperglycemic mouse model. Diabetes. 55: 93-101. PMID 16380481 DOI: 10.2337/Diabetes.55.01.06.Db05-0633 |
0.37 |
|
| 2005 |
Trigatti BL. Hepatic high-density lipoprotein receptors: roles in lipoprotein metabolism and potential for therapeutic modulation. Current Atherosclerosis Reports. 7: 344-50. PMID 16105476 |
0.354 |
|
| 2004 |
Trigatti B, Covey S, Rizvi A. Scavenger receptor class B type I in high-density lipoprotein metabolism, atherosclerosis and heart disease: lessons from gene-targeted mice. Biochemical Society Transactions. 32: 116-20. PMID 14748727 DOI: 10.1042/Bst0320116 |
0.692 |
|
| 2003 |
Trigatti BL, Krieger M, Rigotti A. Influence of the HDL receptor SR-BI on lipoprotein metabolism and atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology. 23: 1732-8. PMID 12920050 DOI: 10.1161/01.ATV.0000091363.28501.84 |
0.494 |
|
| 2003 |
Covey SD, Krieger M, Wang W, Penman M, Trigatti BL. Scavenger receptor class B type I-mediated protection against atherosclerosis in LDL receptor-negative mice involves its expression in bone marrow-derived cells. Arteriosclerosis, Thrombosis, and Vascular Biology. 23: 1589-94. PMID 12829524 DOI: 10.1161/01.Atv.0000083343.19940.A0 |
0.696 |
|
| 2002 |
Braun A, Trigatti BL, Post MJ, Sato K, Simons M, Edelberg JM, Rosenberg RD, Schrenzel M, Krieger M. Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice. Circulation Research. 90: 270-6. PMID 11861414 DOI: 10.1161/hh0302.104462 |
0.403 |
|
| 2002 |
Holm TM, Braun A, Trigatti BL, Brugnara C, Sakamoto M, Krieger M, Andrews NC. Failure of red blood cell maturation in mice with defects in the high-density lipoprotein receptor SR-BI. Blood. 99: 1817-24. PMID 11861300 DOI: 10.1182/Blood.V99.5.1817 |
0.506 |
|
| 2001 |
Trigatti BL, Rigotti A, Braun A. Cellular and physiological roles of SR-BI, a lipoprotein receptor which mediates selective lipid uptake. Biochimica Et Biophysica Acta. 1529: 276-86. PMID 11111095 DOI: 10.1016/S1388-1981(00)00154-2 |
0.47 |
|
| 2001 |
Mardones P, Quinones V, Amigo L, Moreno M, Miquel JF, Schwarz M, Miettinen HE, Trigatti B, Krieger M, Vanpatten S, Cohen DE, Rigotti A. Hepatic cholesterol and bile acid metabolism and intestinal cholesterol absorption in scavenger receptor class B type I (SR-BI)-deficient mice Gastroenterology. 120: A65. DOI: 10.1016/S0016-5085(08)80320-4 |
0.549 |
|
| 2000 |
Trigatti B, Rigotti A, Krieger M. The role of the high-density lipoprotein receptor SR-BI in cholesterol metabolism Current Opinion in Lipidology. 11: 123-131. PMID 10787173 DOI: 10.1097/00041433-200004000-00004 |
0.535 |
|
| 1999 |
Trigatti B, Rayburn H, Viñals M, Braun A, Miettinen H, Penman M, Hertz M, Schrenzel M, Amigo L, Rigotti A, Krieger M. Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology Proceedings of the National Academy of Sciences of the United States of America. 96: 9322-9327. PMID 10430941 DOI: 10.1073/Pnas.96.16.9322 |
0.573 |
|
| 1998 |
Gu X, Trigatti B, Xu S, Acton S, Babitt J, Krieger M. The efficient cellular uptake of high density lipoprotein lipids via scavenger receptor class B type I requires not only receptor-mediated surface binding but also receptor-specific lipid transfer mediated by its extracellular domain Journal of Biological Chemistry. 273: 26338-26348. PMID 9756864 DOI: 10.1074/Jbc.273.41.26338 |
0.507 |
|
| 1997 |
Temel RE, Trigatti B, Demattos RB, Azhar S, Krieger M, Williams DL. Scavenger receptor class B, type I (SR-BI) is the major route for the delivery of high density lipoprotein cholesterol to the steroidogenic pathway in cultured mouse adrenocortical cells Proceedings of the National Academy of Sciences of the United States of America. 94: 13600-13605. PMID 9391072 DOI: 10.1073/Pnas.94.25.13600 |
0.504 |
|
| 1997 |
Rigotti A, Trigatti BL, Penman M, Rayburn H, Herz J, Krieger M. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism Proceedings of the National Academy of Sciences of the United States of America. 94: 12610-12615. PMID 9356497 DOI: 10.1073/Pnas.94.23.12610 |
0.48 |
|
| 1997 |
Rigotti A, Trigatti B, Babitt J, Penman M, Xu S, Krieger M. Scavenger receptor BI - A cell surface receptor for high density lipoprotein Current Opinion in Lipidology. 8: 181-188. PMID 9211067 DOI: 10.1097/00041433-199706000-00009 |
0.506 |
|
| 1997 |
Babitt J, Trigatti B, Rigotti A, Smart EJ, Anderson RGW, Xu S, Krieger M. Murine SR-BI, a high density lipoprotein receptor that mediates selective lipid uptake, is N-glycosylated and fatty acylated and colocalizes with plasma membrane caveolae Journal of Biological Chemistry. 272: 13242-13249. PMID 9148942 DOI: 10.1074/Jbc.272.20.13242 |
0.524 |
|
| Show low-probability matches. |